The 20 Best Infantile Neutropenia Doctors Near Me in District of Columbia, US

Murray Pollack is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 52 years. Dr. Pollack is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. His clinical expertise encompasses Cerebral Hypoxia, Multisystem Inflammatory Syndrome in Children (MIS-C), High Blood Pressure in Infants, and Infantile Neutropenia. Dr. Pollack is board certified in Pediatric Critical Care Medicine: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1979.

Alexandra Freeman is a Pediatric Infectious Disease provider practicing medicine in Washington, Washington, D.c.. Dr. Freeman is rated as an Advanced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Infantile Neutropenia, Chronic Graft Versus Host Disease (cGvHD), Boils, DRESS Syndrome, and Prostatectomy.

Blachy Davila is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Davila is rated as an Advanced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Hemophagocytic Lymphohistiocytosis, Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

Lindsay Kilburn, MD, comes to Children's National Hospital from Texas Children’s Hospital in Houston, TX, where she was an assistant professor of pediatrics in the neuro-oncology and pharmacology programs. Dr. Kilburn graduated with a degree in Environmental Sciences from the University of Virginia. After graduating from Eastern Virginia Medical School, she completed her pediatric training at the Children’s Hospital of The King’s Daughters in Norfolk, VA, and her hematology/oncology fellowship at Texas Children’s Hospital/Baylor College of Medicine in Houston, TX. She also has received training in pharmacology from both Thomas Jefferson University in Philadelphia and the Baylor College of Medicine in Houston. Dr. Kilburn is an associate professor, pediatrics at George Washington University School of Medicine. Her research focuses on the development and evaluation of new therapeutic agents for children with pediatric brain tumors through clinical trials. She is committed to the improvement of palliative and supportive care. Dr. Kilburn grew up outside of Philadelphia and is married with young twins. Outside of work, she enjoys sailing, hiking, and traveling with her family. Dr. Kilburn is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Glioma, and Optic Glioma. Dr. Kilburn is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 2004.

"Eugene (Gene) Hwang, MD, is chief of the Division of Oncology at Children’s National Hospital in Washington, D.C. He is also part of the Children's National Hospital pediatric neuro-oncology team, focusing on treating children with brain tumors. Dr. Hwang has developed and led many novel early phase therapeutic clinical trials with a focus on immunotherapeutic trials, and he also leads trials focused on gene therapy and new, targeted agents. He is the site Principal Investigator of the Pediatric Brain Tumor Consortium, where he is the co-chair of the Immunotherapy Working Group. He serves on grant review committees and on the scientific advisory boards of several large foundations. For each patient, Dr. Hwang carefully considers the best possible options for treatment, trying new, cutting edge treatments coupled with the best available known therapies. Dr. Hwang is not only dedicated to finding a cure for cancer, but also to making the current treatments as safe as possible for children: ""We often focus on curing the children - that's the number one goal - but we also need to pay attention to the toxicity of these treatments, and what quality of life the children will have after treatment."" Dr. Hwang is involved in several international efforts to study how to best mitigate treatment side effects. In the meantime, Dr. Hwang makes sure he is doing everything he can to combat pain, dizziness, fatigue and other common side effects of cancer treatments by leveraging the multidisciplinary team approach of Children's National. He sees this as something the organization does exceptionally well, and thinks that having so many people focus on a single patient in a single visit is crucial to well-being during cancer treatment.". Dr. Hwang is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pineocytoma, Glioma, Medulloblastoma, and Pineoblastoma. Dr. Hwang is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 2005.

Craig Shapiro, MD, is an infectious diseases specialist in the Division of Infectious Diseases at Children's National Hospital in Washington, D.C., and an assistant professor of pediatrics at the George Washington University School of Medicine and Health Sciences. His research and clinical interests involve applying quality improvement processes to develop better efficiency in antibiotic ordering and diagnostic testing for infections. Dr. Shapiro enjoys golfing, biking and traveling with his family. Dr. Shapiro is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. His clinical expertise encompasses Bacterial Meningitis, Infantile Neutropenia, Malaria, and Osteomyelitis in Children. Dr. Shapiro is board certified in American Board Of Pediatrics, 2013 and American Board Of Pediatrics, 2009.

Nita L. Seibel, MD, is a board-certified pediatrician and pediatric hematologist-oncologist. After graduating from the Ohio State University College of Medicine in 1988, she completed her internship and residency at the Ohio State University Children’s Hospital in 1984. Dr. Seibel completed a fellowship in pediatric hematology-oncology at the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health in 1987. She joined the faculty of Children's National Hospital in 1988 and is a professor of pediatrics at the George Washington University School of Medicine & Health Sciences. While at Children's National, Dr. Seibel has served for over 15 years on the Institutional Review Board, as Director of the Hematology/Oncology Training Program for nine years and as Principal Investigator for Children's Oncology Group. Dr. Seibel has chaired numerous studies for the Children’s Oncology Group including chairing the Phase I Data Safety Monitoring Committee and served as vice-chair for Phase I agents. Dr. Seibel was also a member of the National Wilms Tumor Study and later the COG Renal Tumor Committee. Dr. Seibel's areas of special interest are: Wilms tumor, bone tumors, ALL, and adolescent and young adult oncology as well as late effects. She also has a special interest in Acute Lymphoblastic Leukemia in adolescents and young adults and anti-fungal agents. Dr. Seibel is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult Soft Tissue Sarcoma, and Infantile Neutropenia. Dr. Seibel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1986.

Jeffrey Dome, MD, PhD, is senior vice president of the Cancer and Blood Disorders Center at Children’s National Hospital in Washington, D.C. He is professor of pediatrics at the George Washington University School of Medicine and Health Sciences and the Thomas Willson and Lenore Williams McKnew professor of pediatric oncology. Dr. Dome received his medical degree from the University of Pennsylvania School of Medicine and PhD degree in medicine from Erasmus University in Rotterdam. He completed a residency in pediatrics at Yale-New Haven Hospital and completed a fellowship in pediatric hematology/oncology at Johns Hopkins Hospital. After fellowship, Dr. Dome was a faculty member at St. Jude Children’s Research Hospital before joining Children’s National in 2006. Dr. Dome is an internationally recognized expert on pediatric solid tumors, with an emphasis on kidney tumors and sarcomas. He chaired the Children’s Oncology Group (COG) Renal Tumor Committee for more than a decade. He is presently on the Scientific Council of the COG, the editorial board of Pediatric Blood and Cancer, and is past chair of the American Board of Pediatrics Subboard of Hematology/Oncology. Dr. Dome serves on numerous medical advisory boards for cancer foundations and currently is the North American Continental President of the International Society of Pediatric Oncology (SIOP). He has authored more than 200 articles, books, letters and chapters on pediatric cancer. Dr. Dome is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Denys-Drash Syndrome (DDS), Adult Soft Tissue Sarcoma, Nephrectomy, and Bone Marrow Aspiration. Dr. Dome is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1998.

Catherine Bollard is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Bollard is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Graft Versus Host Disease (GvHD), Leukemia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Reuven Schore, MD, is a pediatric oncologist and a member of the Leukemia/Lymphoma Program at Children's National Hospital. Dr. Schore is an associate professor, pediatrics at George Washington University School of Medicine. Dr. Schore is the vice chair for a Children's Oncology Group study investigating intravenous treatments for patients with high-risk acute lymphoblastic leukemia (ALL). Dr. Schore is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Juvenile Myelomonocytic Leukemia (JMML), and Febrile Neutropenia. Dr. Schore is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006 and Pediatrics: American Board Of Pediatrics, 2003.

Jaclyn Kline, MD, is an emergency medicine physician at Children's National. She grew up outside of Pittsburgh, PA, and went to medical school at Virginia Commonwealth University in Richmond. She then completed a residency in pediatrics at Brown University, where she was also chief resident, before finishing a fellowship in pediatric emergency medicine at Children's National. Outside of her clinical work treating children in the Emergency Department, she is interested in quality improvement and standardizing evidence-based care for all children in the Emergency Department. Dr. Kline is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Pediatric Myocarditis, Hypotonia, and Infantile Neutropenia. Dr. Kline is board certified in American Board Of Preventive Medicine, 2024, Pediatric Emergency Medicine: American Board Of Pediatrics, 2019, and American Board Of Pediatrics, 2013.

Andrea Hahn, MD, MS, is an infectious disease specialist in the Division of Infectious Diseases at Children’s National Hospital and a tenured associate professor of pediatrics at George Washington University in Washington, D.C. She completed medical school at the Ohio State University in 2008, her pediatric residency at Nationwide Children’s Hospital in Columbus, Ohio, in 2011 and her pediatric infectious diseases and clinical pharmacology fellowships at Cincinnati Children’s Hospital Medical Center in 2014. Dr. Hahn is board-certified in pediatrics, pediatric infectious diseases and clinical pharmacology. Dr. Hahn was awarded a National Institutes of Health (NIH) T32 training grant in pediatric clinical pharmacology from 2012-2014, as well as an NIH K12 training grant in the omics of lung disease in children from 2014-2017. She has also received research funding from the NIH Loan Repayment Program, the Clark Charitable Trust and the Margaret Q. Landenberger Foundation. Dr. Hahn has been continuously funded by the Cystic Fibrosis Foundation since 2018, studying the impact of antibiotics on the airway microbiome and Pseudomonas aeruginosa extracellular vesicles on lung inflammation. She is also co-investigator on several NIH studies evaluating bacterial and viral infections in children with tracheostomy. Her expertise includes pharmacokinetic modeling of antimicrobials, the airway microbiome and antimicrobial resistance in children with cystic fibrosis and children with tracheostomy. Dr. Hahn is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Asthma in Children, Parainfluenza, Cat Scratch Disease, and Bacterial Meningitis. Dr. Hahn is board certified in Pediatric Infectious Diseases: American Board Of Pediatrics, 2015.

Upendra Mahat is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 18 years. Dr. Mahat is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. His clinical expertise encompasses Classical Hodgkin Lymphoma, Infantile Neutropenia, Atypical Hemolytic Uremic Syndrome (aHUS), and Immune Thrombocytopenic Purpura (ITP). Dr. Mahat is board certified in American Board Of Pediatrics, 2023 and Pediatrics: American Board Of Pediatrics, 2020.

Anant Vatsayan, MBBS, is a blood and marrow transplant/cellular therapy attending at Children’s National Hospital. He is an assistant professor of pediatrics at the George Washington School of Medicine and Health Sciences, the cellular therapy laboratory medical director, and the pediatric BMT fellowship director for the joint NCI/Children’s National Hospital BMT Fellowship Program. He is a board-certified pediatric hematologist/oncologist. Prior to joining Children’s National, Dr. Vatsayan completed a two-year fellowship in cellular therapy/blood and marrow transplantation (BMT) at Memorial Sloan Kettering Center, New York. He did his pediatric hematology/oncology fellowship at Rainbow Babies and Children’s Hospital, Case Western Reserve University, Cleveland, Ohio. His research interests include BMT/cellular therapies for pediatric high-risk hematologic malignancies. He is the clinical lead for the Chimeric Antigen Receptor T (CAR-T) therapy program at Children’s National. His other interests include novel transplantation techniques like TCR alpha/beta T cell depleted BMT, graft versus host disease and BMT for high-risk inherited bone marrow failure syndromes, like Fanconi anemia. Dr. Vatsayan is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. His clinical expertise encompasses Non-Langerhans-Cell Histiocytosis, Hemophagocytic Lymphohistiocytosis, Acquired Amegakaryocytic Thrombocytopenia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant. Dr. Vatsayan is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2017 and Pediatrics: American Board Of Pediatrics, 2013.

Aviva Krauss is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Krauss is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. Her clinical expertise encompasses Infantile Neutropenia, Osteosclerosis Autosomal Dominant, Graft Versus Host Disease (GvHD), Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Transplant.

Sara Silbert is a Palliative Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Silbert is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. Her clinical expertise encompasses Infantile Neutropenia and Secondary Immunodeficiency (SID).

David Wessel is a Pediatric Cardiologist practicing medicine in Washington, Washington, D.c.. Dr. Wessel is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), High Blood Pressure in Infants, Cerebral Hypoxia, and Pulmonary Hypertension.

Corina Gonzalez is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Gonzalez is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Infantile Neutropenia, Chronic Graft Versus Host Disease (cGvHD), X-Linked Severe Combined Immunodeficiency, and Bone Marrow Transplant.

Roger Packer is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Packer is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Gliomatosis Cerebri.

Caileigh Pudela is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Pudela is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. Her clinical expertise encompasses Neuroblastoma, Infantile Neutropenia, Embryonal Tumor with Multilayered Rosettes, and Immune Thrombocytopenic Purpura (ITP).